4//SEC Filing
MACK DAVID J. 4
Accession 0001104659-25-020519
CIK 0001720893other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 9:21 PM ET
Size
7.2 KB
Accession
0001104659-25-020519
Insider Transaction Report
Form 4
MACK DAVID J.
Director
Transactions
- Exercise/Conversion
Common Stock
2025-02-28+1,693→ 6,772 total - Exercise/Conversion
Restricted Stock Units
2025-02-28−1,693→ 13,545 total→ Common Stock (1,693 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]On November 21, 2024, the Reporting Person was granted 20,317 RSUs, vesting in twelve equal installments on the last day of each month beginning on November 30, 2024, subject to his continued service as a Director through the vesting period.
Documents
Issuer
BioXcel Therapeutics, Inc.
CIK 0001720893
Entity typeother
Related Parties
1- filerCIK 0001694466
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 9:21 PM ET
- Size
- 7.2 KB